{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:18:30Z","timestamp":1791494310127,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012269","name":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/501100012269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grants-in-Aid for Scientific Research (research on hypothalamic-hypophyseal disorders) from the Ministry of Health, Labor and Welfare of Japan","award":["2"],"award-info":[{"award-number":["2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Plasma renin activity (PRA) is generally increased in patients with pheochromocytoma (PCC) due to low circulating plasma volume and activation of \u03b2-1 adrenergic receptor signaling. However, there has been no study on the aldosterone renin ratio (ARR) in patients with PCC. To elucidate the issue, this study aimed to determine the PRA, plasma aldosterone concentration (PAC), and ARR in patients with PCC and compare them with those in patients with subclinical Cushing\u2019s syndrome (SCS) and non-functioning adrenal adenoma (NFA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective single-center, cross-sectional study, 67 consecutive patients with adrenal tumors (PCC (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918), SCS (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918), and NFA (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200931)) diagnosed at Kobe University Hospital between 2008 and 2014 were enrolled.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PRA was significantly higher in patients with PCC than in those with SCS and NFA (2.1 (1.3\u2009~\u20092.8) vs. 0.7 (0.5\u2009~\u20091.8) and 0.9 (0.6\u2009~\u20091.4) ng\/mL\/h;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025). Although PACs were comparable among the three groups, ARR was significantly lower in patients with PCC than in those with SCS and NFA (70.5 (45.5\u2009~\u200979.5) vs. 156.0 (92.9\u2009~\u2009194.5) and 114.9 (90.1\u2009~\u2009153.4);\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Receiver operating characteristic curve analysis demonstrated that, in differentiating PCC from NFA, PRA &gt;\u20091.55\u2009ng\/mL\/h showed a sensitivity of 70.0% and specificity of 80.6%. Interestingly, ARR &lt;\u200995.4 showed a sensitivity of 83.3% and specificity of 86.7%, which were higher than those in PRA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ARR decreased in patients with PCC, which was a more sensitive marker than PRA. Further study is necessary to understand the usefulness of this convenient marker in the detection of PCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This study was not registered because of the retrospective analysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-020-00620-6","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T08:02:41Z","timestamp":1599811361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Patients with pheochromocytoma exhibit low aldosterone renin ratio-preliminary reports"],"prefix":"10.1186","volume":"20","author":[{"given":"Tomoko","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-653X","authenticated-orcid":false,"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusei","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Odake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusaku","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genzo","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"issue":"11","key":"620_CR1","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1210\/jc.2007-1720","volume":"92","author":"K Pacak","year":"2007","unstructured":"Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92(11):4069\u201379.","journal-title":"J Clin Endocrinol Metab"},{"key":"620_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1213\/00000539-197201000-00010","volume":"51","author":"LB Perry","year":"1972","unstructured":"Perry LB, Gould AB Jr. The anesthetic management of pheochromocytoma effect of preoperative adrenergic blocking drugs. Anesth Analg. 1972;51:36\u201340.","journal-title":"Anesth Analg"},{"issue":"5","key":"620_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1365-2265.2007.02805.x","volume":"66","author":"CG Perry","year":"2007","unstructured":"Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J, Young WF Jr. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol. 2007;66(5):703\u20138.","journal-title":"Clin Endocrinol"},{"issue":"11","key":"620_CR4","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","volume":"287","author":"JW Lenders","year":"2002","unstructured":"Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287(11):1427\u201334.","journal-title":"JAMA."},{"issue":"3","key":"620_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1530\/eje.1.02097","volume":"154","author":"N Unger","year":"2006","unstructured":"Unger N, Pitt C, Schmidt IL, Walz MK, Schmid KW, Philipp T, et al. Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol. 2006;154(3):409\u201317.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"620_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/00313020802579284","volume":"41","author":"PE Hickman","year":"2009","unstructured":"Hickman PE, Leong M, Chang J, Wilson SR, McWhinney B. Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma. Pathology. 2009;41(2):173\u20137.","journal-title":"Pathology."},{"issue":"5","key":"620_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1530\/EJE-09-0996","volume":"162","author":"E Grouzmann","year":"2010","unstructured":"Grouzmann E, Drouard-Troalen L, Baudin E, Plouin PF, Muller B, Grand D, et al. Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. Eur J Endocrinol. 2010;162(5):951\u201360.","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"620_CR8","first-page":"86","volume":"19","author":"SK Kota","year":"2012","unstructured":"Kota SK, Kota SK, Panda S, Modi KD. Pheochromocytoma: an uncommon presentation of an asymptomatic and biochemically silent adrenal incidentaloma. Malays J Med Sci. 2012;19(12):86\u201391.","journal-title":"Malays J Med Sci"},{"issue":"1","key":"620_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/cs0840001","volume":"84","author":"O Sk\u00f8tt","year":"1993","unstructured":"Sk\u00f8tt O, Jensen BL. Cellular and intrarenal control of renin secretion. Clin Sci. 1993;84(1):1\u201310.","journal-title":"Clin Sci"},{"issue":"4","key":"620_CR10","first-page":"F418","volume":"244","author":"U Kopp","year":"1983","unstructured":"Kopp U, DiBona GF. Interaction of renal beta 1-adrenoceptors and prostaglandins in reflex renin release. Am J Phys. 1983;244(4):F418\u201324.","journal-title":"Am J Phys"},{"issue":"6","key":"620_CR11","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH. Et al; Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"620_CR12","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"620_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4158\/EP.15.5.450","volume":"15","author":"MA Zeiger","year":"2009","unstructured":"Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, American Association of Clinical Endocrinologists; American Association of Endocrine Surgeons, et al. American Association of Endocrine Surgeons. American Association of Clinical Endocrinologists and American Association of endocrine surgeons medical guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. Endocr Pract. 2009;15(5):450\u20133.","journal-title":"Endocr Pract"},{"issue":"9","key":"620_CR14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1001\/archsurg.142.9.870","volume":"142","author":"JA Lee","year":"2007","unstructured":"Lee JA, Zarnegar R, Shen WT, Kebebew E, Clark OH, Duh QY. Adrenal incidentaloma, borderline elevations of urine or plasma metanephrine levels, and the \"subclinical\" pheochromocytoma. Arch Surg. 2007;142(9):870\u20134.","journal-title":"Arch Surg"},{"issue":"5","key":"620_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/jso.24031","volume":"112","author":"MG Heavner","year":"2015","unstructured":"Heavner MG, Krane LS, Winters SM, Mirzazadeh M. Pheochromocytoma diagnosed pathologically with previous negative serum markers. J Surg Oncol. 2015;112(5):492\u20135.","journal-title":"J Surg Oncol"},{"issue":"1\u20133","key":"620_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0167-0115(03)00021-1","volume":"112","author":"CJ Charles","year":"2003","unstructured":"Charles CJ, Lainchbury JG, Nicholls MG, Rademaker MT, Richards AM, Troughton RW. Adrenomedullin and the renin-angiotensin-aldosterone system. Regul Pept. 2003;112(1\u20133):41\u20139.","journal-title":"Regul Pept"},{"issue":"3","key":"620_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1210\/edrv-15-3-356","volume":"15","author":"EL Bravo","year":"1994","unstructured":"Bravo EL. Evolving concepts in the pathophysiology, diagnosis, and treatment of Pheochromocytoma. Endocr Rev. 1994;15(3):356\u201368.","journal-title":"Endocr Rev"},{"issue":"5","key":"620_CR18","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.3892\/ol.2015.3660","volume":"10","author":"W Hu","year":"2015","unstructured":"Hu W, Shi L, Zhou PH, Zhang XB. Plasma concentrations of adrenomedullin and atrial and brain natriuretic peptides in patients with adrenal pheochromocytoma. Oncol Lett. 2015;10(5):3163\u201370.","journal-title":"Oncol Lett"},{"issue":"4652","key":"620_CR19","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1126\/science.6326267","volume":"224","author":"K Atarashi","year":"1984","unstructured":"Atarashi K, Mulrow PJ, Franco-Saenz R, Snajdar R, Rapp J. Inhibition of aldosterone production by an atrial extract. Science. 1984;224(4652):992\u20134.","journal-title":"Science."},{"issue":"8","key":"620_CR20","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1590\/S0100-879X2004000800016","volume":"37","author":"MG Nicholls","year":"2004","unstructured":"Nicholls MG. Hemodynamic and hormonal actions of adrenomedullin. Braz J Med Biol Res. 2004;37(8):1247\u201353.","journal-title":"Braz J Med Biol Res"},{"issue":"8","key":"620_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00268-002-6667-z","volume":"26","author":"C Prys-Roberts","year":"2002","unstructured":"Prys-Roberts C, Farndon JR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg. 2002;26(8):1037\u201342.","journal-title":"World J Surg"},{"issue":"10","key":"620_CR22","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.mayocp.2019.03.030","volume":"94","author":"E Buitenwerf","year":"2019","unstructured":"Buitenwerf E, Berends AMA, van Asselt ADI, Korteweg T, Greuter MJW, Veeger NJM, et al. Diagnostic accuracy of computed tomography to exclude Pheochromocytoma: a systematic review, meta-analysis, and cost analysis. Mayo Clin Proc. 2019;94(10):2040\u201352.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"620_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-2265.2008.03256.x","volume":"69","author":"KS Bhatia","year":"2008","unstructured":"Bhatia KS, Ismail MM, Sahdev A, Rockall AG, Hogarth K, Canizales A, et al. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extraadrenal phaeochromocytomas: CT and MRI correlation. Clin Endocrinol. 2008;69(2):181\u20138.","journal-title":"Clin Endocrinol"},{"issue":"9","key":"620_CR24","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.2967\/jnumed.108.058701","volume":"50","author":"GA Wiseman","year":"2009","unstructured":"Wiseman GA, Pacak K, O'Dorisio MS, Neumann DR, Waxman AD, Mankoff DA, et al. Usefulness of 123IMIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med. 2009;50(9):1448\u201354.","journal-title":"J Nucl Med"},{"issue":"10","key":"620_CR25","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1210\/jc.2009-1054","volume":"94","author":"HB Fiebrich","year":"2009","unstructured":"Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, et al. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab. 2009;94(10):3922\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"620_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000242499","volume":"91","author":"R Milardovic","year":"2010","unstructured":"Milardovic R, Corssmit EP, Stokkel M. Value of 123I-MIBG scintigraphy in paraganglioma. Neuroendocrinology. 2010;91(1):94\u2013100.","journal-title":"Neuroendocrinology."},{"issue":"6","key":"620_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, et al. Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002;40(6):897\u2013902.","journal-title":"Hypertension"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00620-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-020-00620-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00620-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T19:23:09Z","timestamp":1631301789000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-020-00620-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1186\/s12902-020-00620-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.22519\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22519\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22519\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22519\/v3","asserted-by":"object"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and its amendments, and it was approved by the institutional review boards of the participating facilities (Kobe University Hospital ethical committee; IRB #1351). Written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests\u201d in this section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}